Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Obesity Reports
Published in: Current Obesity Reports 1/2016

01-03-2016 | Psychological Issues (M Hetherington and V Drapeau, Section Editors)

Satiety Innovations: Food Products to Assist Consumers with Weight Loss, Evidence on the Role of Satiety in Healthy Eating: Overview and In Vitro Approximation

Authors: Rubén López-Nicolás, Massimo Marzorati, Lia Scarabottolo, Jason C. G. Halford, Alexandra M. Johnstone, Carmen Frontela-Saseta, Angel M. Sanmartín, Gaspar Ros-Berruezo, Joanne A. Harrold

Published in: Current Obesity Reports | Issue 1/2016

Login to get access

Abstract

The prevalence of overweight and obesity is increasing globally, driven by the availability of energy-dense palatable foods. Most dietary strategies fail because of hunger generated by calorie restriction, and interventions that specifically control hunger and/or promote fullness may aid success. Current consumers have a limited choice of satiety-enhancing products with proven health benefits, and innovative ways to produce new foods (as structural modification) to enhance satiety/satiation may provide new opportunities. However, this potential is hindered by the cost of product testing. Within the SATIN—SATiety INnovation project—an in vitro platform has been developed to offer a cost-effective means of assessing the potential satiation/satiety effect of novel foods. This combines in vitro technologies to assess changes in colonic bacteria metabolism, appetite hormone release and the stability and bioavailability of active compounds in the new products/ingredients. This article provides a brief review of nutrients for which an impact on short-term appetite regulation has been demonstrated, and a summary of the changes to food structure which can be used to produce a change in appetite expression. Furthermore, the SATIN in vitro platform is discussed as a means of assessing the impact of nutritional and structural manipulations on appetite.
Literature
1.
Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des. 2009;15(13):1546–58.CrossRefPubMed
2.
Kalm LM, Semba RD. They starved so that others be better fed: remembering Ancel keys and the Minnesota experiment. J Nutr. 2005;135:1347–52.PubMed
3.
Stubbs J, Pallister C, Avery A, et al. Weight, body mass index and behaviour change in a commercially run lifestyle programme for young people. J Hum Nutr Diet. 2012;25(2):161–6.CrossRefPubMed
4.
Halford JCG, Harrold JA. Satiety-enhancing products for appetite control: science and regulation of functional foods for weight management. Proc Nutr Soc. 2012;71:350–62.CrossRefPubMed
5.
6.
Van Kleef E, Van Trijp JCM, Van Den Borne JJGC, Zondervan C. Successful development of satiety enhancing food products: towards a multidisciplinary agenda of research challenges. Crit Rev Food Sci Nutr. 2012;52(7):611–28.CrossRefPubMedPubMedCentral
7.
8.
Johnstone AM. Safety and efficacy of high-protein diets for weight loss. Proc Nutr Soc. 2012;71(2):339–49.CrossRefPubMed
9.
Westerterp-Plantenga MS, Rolland V, Wilson SAJ, et al. Satiety related to 24 h diet-induced thermogenesis during high protein carbohydrate vs high fat diets measured in a respiration chamber. Eur J Clin Nutr. 1999;53(6):495–502.CrossRefPubMed
10.
Skov AR, Toubro S, Ronn B, et al. Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J Obes. 1999;23(5):528–36.CrossRef
11.
Larsen TM, Dalskov S-M, van Baak M, et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med. 2010;363(22):2102–13.CrossRefPubMedPubMedCentral
12.
Eisenstein J, Roberts SB, Dallai G, et al. High-protein weight-loss diets: are they safe and do they work? A review of the experimental and epidemiological data. Nutr Rev. 2002;60:189–200.CrossRefPubMed
13.
Westerterp-Plantenga MS, Lejeune MP. Protein intake and body weight regulation. Appetite. 2005;45:187–90.CrossRefPubMed
14.
Pesta DH, Samuel VT. A high-protein diet for reducing body fat: mechanisms and possible caveats. Nutr Metab. 2014;11:53.CrossRef
15.
Veldhorst MA, Nieuwenhuizen AG, Hochstenbach-Waelen A, et al. Dose-dependent satiating effect of whey relative to casein or soy. Physiol Behav. 2009;96(4–5):675–82.CrossRefPubMed
16.
Gilbert JA, BEnden NT, Tremblay A, et al. Effects of proteins from different sources on body composition. Nutr Metab Cardiovasc Dis. 2011;21:B16–31.CrossRefPubMed
17.
Wanders AJ, van den Born JJGC, de Graaf C, et al. Effect of dietary fibre on subjective appetite, energy intake and body weight: a systematic review of randomised controlled trials. Obes Rev. 2011;12:724–39.PubMed
18.
Astrup A, Vrist E, Quaade F. Dietary fibre added to very low calorie diet reduced hunger and alleviates constipation. Int J Obes. 1990;14(2):105–12.PubMed
19.
Rigaud D, Ryttig KR, Leeds AR, et al. Effects of a moderate dietary fibre supplement on hunger rating, energy input and faecal energy output in young, healthy volunteers. A randomized, double-blind cross-over trial. Int J Obes. 1987;1:73–8.
20.
Aston LM, Stokes CS, Jebb SA. No effect of a diet with a reduced glycemic index on satiety, energy intake and body weight in overweight and obese women. Int J Obes. 2008;32(1):160–5.CrossRef
21.
Burton-Freeman B. Dietary fiber and energy regulation. J Nutr. 2000;130(2):2725–55.
22.
Dikeman CL, Fahey GC. Viscosity as related to dietary fibre: a review. Crit Rev Food Sci Nutr. 2006;46(8):649–63.CrossRefPubMed
23.
Vuksan V, Panahi S, Lyon M, et al. Viscosity of fiber preloads affects food intake in adolescents. Nutr Metab Cardiovasc Dis. 2009;19:498–503.CrossRefPubMed
24.
Howarth NC, Saltzman E, Roberts SB. Dietary fiber and weight regulation. Nutr Rev. 2001;59(5):129–39.CrossRefPubMed
25.
Hoad CL, Rayment P, Spiller RC, et al. In vivo imaging of intragastric gelation and its effect on satiety in humans. J Nutr. 2001;134:2293–300.
26.
Behall KM, Scholfield DJ, Hallfrisch JG, et al. Consumption of both resistant starch and beta-glucan improves postprandial plasma glucose and insulin in women. Diabetes Care. 2006;29:976–81.CrossRefPubMed
27.
Casiraghi MC, Garsetti M, Testolin G, et al. Post-prandial responses to cereal products enriched with barley beta-glucan. J Am Coll Nutr. 2006;25(4):313–20.CrossRefPubMed
28.
Raben A, Tagliabue A, Christensen NJ, et al. Resistant starch: the effect on postprandial glycemia, hormonal response and satiety. Am J Clin Nutr. 1994;60(4):544–51.PubMed
29.
de Roos N, Heijnen ML, de Graaf C, et al. Resistant starch has little effect on appetite, food intake and insulin secretion in healthy young men. Eur J Clin Nutr. 1995;49(7):532–41.PubMed
30.
Nilsson AC, Ostman EM, Holst JJ, et al. Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. J Nutr. 2008;138:732–9.PubMed
31.
32.
Di Meglio D, Matts RD. Liquid versus solid carbohydrates: effects on food intake and body weight. Int J Obes. 2000;24:794–800.CrossRef
33.
Almiron-Roig E, Chen Y, Drewnowski A. No difference in satiety or in subsequent energy intakes between a beverage and a solid food. Physiol Behav. 2004;82:671–7.CrossRefPubMed
34.
Kristensen M, Jensen MG. Dietary fibres in the regulation of appetite and food intake. Importance of viscosity. Appetite. 2011;56:65–70.CrossRefPubMed
35.
Wolf BW, Lai CS, Kipnes MS, et al. Glycemic and insulinemic responses of non-diabetic healthy adult subjects to an experimental acid-induced viscosity complex incorporated into a glucose beverage. Nutrition. 2002;18:621–6.CrossRefPubMed
36.
Turnbaugh PJ, Ridaura VK, Faith JJ, et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009;1(6).
37.
38.
Zhou J, Martin RJ, Tulley RT, et al. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab. 2008;295(5):E1160–6.CrossRefPubMedPubMedCentral
39.
Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101(44):15718–23.CrossRefPubMedPubMedCentral
40.
Possemiers S, Grootaert C, Vermeiren J, et al. The intestinal environment in health and disease—recent insights on the potential of intestinal bacteria to influence human health. Curr Pharm Des. 2009;15(18):2051–65.CrossRefPubMed
41.
de Wiele TV, Boon N, Possemiers S, et al. Prebiotic effects of chicory inulin in the simulator of the human intestinal microbial ecosystem. FEMS Microbiol Ecol. 2004;51(1):143–53.CrossRefPubMed
42.
Terpend K, Possemiers S, Daguet D, et al. Arabinogalactan and fructo-oligosaccharides have a different fermentation profile in the Simulator of the Human Intestinal Microbial Ecosystem (SHIME®). Environ Microbiol Rep. 2013;5(4):595–603.CrossRefPubMed
43.
Marzorati M, Possemiers S, Verhelst A, et al. A novel hypromellose capsule, with acid resistance properties, permits the targeted delivery of acid-sensitive products to the intestine. LWT Food Sci Technol. 2015;60(1):544–51.CrossRef
44.
Sanchez JI, Marzorati M, Grootaert C, et al. Arabinoxylan-oligosaccharides (AXOS) affect the protein/carbohydrate fermentation balance and microbial population dynamics of the Simulator of Human Intestinal Microbial Ecosystem. Microb Biotechnol. 2009;2(1):101–13.CrossRefPubMedPubMedCentral
45.•
Van den Abbeele P, Roos S, Eeckhaut V, et al. Incorporating a mucosal environment in a dynamic gut model results in a more representative colonization by lactobacilli. Microb Biotechnol. 2012;5(1):106–15. This study provides a thorough description of the maximum degree of complexity a gut simulator can reach with the incorporation of a luminal and mucosal compartment in each colon sector.CrossRefPubMedPubMedCentral
46.
Janssen S, Depoortere I. Nutrient sensing in the gut: new roads to therapeutics? Trends Endocrinol Metab. 2013;24(2):92–100.CrossRefPubMed
47.
48.
Neary MT, Batterham RL. Gut hormones: implications for the treatment of obesity. Pharmacol Ther. 2009;124(1):44–56.CrossRefPubMed
49.
Nguyen CA, Akiba Y, Kaunitz JD. Recent advances in gut nutrient chemosensing. Curr Med Chem. 2012;19(1):28–34.CrossRefPubMed
50.•
Le Neve B, Daniel H. Selected tetrapeptides lead to a GLP-1 release from the human enteroendocrine cell line NCI-H716. Regul Pept. 2011;167(1):14–20. This study demonstrates the potential to use the human NCI-H716 cells as a valid in vitro model to study the induction of GLP-1 secretion upon the application of different stimuli. CrossRefPubMed
51.
Kim K, Lee YM, Rhyu M-R, et al. Spergularia marina induces glucagon-like peptide-1 secretion in NCI-H716 cells through bile acid receptor activation. J Med Food. 2014;17(11):1197–203.CrossRefPubMedPubMedCentral
52.
Hira T, Maekawa T, Asano K, et al. Cholecystokinin secretion induced by beta-conglycinin peptone depends on G alpha q-mediated pathways in enteroendocrine cells. Eur J Nutr. 2009;48(2):124–7.CrossRefPubMed
53.
O'Sullivan L, Ryan L, Aherne SA, et al. Cellular transport of lutein is greater from uncooked rather than cooked spinach irrespective of whether it is fresh, frozen, or canned. Nutr Res. 2008;28(8):532–8.CrossRefPubMed
54.
Laparra JM, Glahn RP, Miller DD. Assessing potential effects of inulin and probiotic bacteria on Fe availability from common beans (Phaseolus vulgaris L.) to Caco-2 cells. J Food Sci. 2009;74(2):H40–6.CrossRefPubMed
55.
Loennerdal B. Soybean ferritin: implications for iron status of vegetarians. Am J Clin Nutr. 2009;89(5):S1680–5.CrossRef
Metadata
Title
Satiety Innovations: Food Products to Assist Consumers with Weight Loss, Evidence on the Role of Satiety in Healthy Eating: Overview and In Vitro Approximation
Authors
Rubén López-Nicolás
Massimo Marzorati
Lia Scarabottolo
Jason C. G. Halford
Alexandra M. Johnstone
Carmen Frontela-Saseta
Angel M. Sanmartín
Gaspar Ros-Berruezo
Joanne A. Harrold
Publication date
01-03-2016
Publisher
Springer US
Published in
Current Obesity Reports / Issue 1/2016
Electronic ISSN: 2162-4968
DOI
https://doi.org/10.1007/s13679-016-0196-9

Other articles of this Issue 1/2016

Current Obesity Reports 1/2016 Go to the issue

Etiology of Obesity (T Gill, Section Editor)

Young Adults’ Attitudes and Perceptions of Obesity and Weight Management: Implications for Treatment Development

Etiology of Obesity (T Gill, Section Editor)

The Link Between Inadequate Sleep and Obesity in Young Adults

Psychological Issues (M Hetherington and V Drapeau, Section Editors)

Restaurant Menu Labeling Policy: Review of Evidence and Controversies

Etiology of Obesity (T Gill, Section Editor)

Weight-Related Dietary Behaviors in Young Adults

Etiology of Obesity (T Gill, Section Editor)

The Health Consequences of Obesity in Young Adulthood

Psychological Issues (M Hetherington and V Drapeau, Section Editors)

Obesity Prevention Programs in Children: Impact on Weight, Shape and Food Concern
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits